Patent · US Active

Indole compounds as androgen receptor modulators

US11667624B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2021
Grant dateJun 6, 2023
Priority date—
Expiry dateJul 20, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are indole compounds that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.